Due Diligence Standards
Every company we represent passes comprehensive evaluation across six criteria:
- Management integrity. We work with founders we trust who run their companies with transparency and ethics.
- IP ownership. Clear, defensible intellectual property without litigation risk.
- Financial sustainability. Realistic capital needs with clear path to revenue.
- Operational capability. Teams that can execute on their development timeline.
- Regulatory pathway. Clear understanding of FDA requirements and approval process.
- Ethical standards. Technology that helps patients and aligns with our values.
Companies that don't meet these standards don't advance. This protects both founders and investors.
About Benoît Lapointe
Ben spent five years as an investment advisor at RBC Dominion Securities in Toronto, working with high-net-worth clients on complex transactions and understanding institutional capital requirements.
For the past 20 years he's focused on healthcare innovation and commercial real estate, completing over $450 million in transactions.
He's bilingual (English and French), holds a business administration degree from Université de Sherbrooke.
He believes healthcare is a human right. That's not a slogan. It's a filter. It attracts the right founders and repels the wrong ones.